Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 109

Results For "24"

2125 News Found

Bayer submits supplemental new drug application to USFDA seeking expanded indication for NUBEQA
Drug Approval | September 29, 2024

Bayer submits supplemental new drug application to USFDA seeking expanded indication for NUBEQA

NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC)


Amcor's long-term SBTi targets confirmed
Sustainability | September 28, 2024

Amcor's long-term SBTi targets confirmed

The net-zero target approval complements the company's near-term emission reduction targets


Zydus receives USFDA final approval for Enzalutamide Capsules, 40 mg
Drug Approval | September 28, 2024

Zydus receives USFDA final approval for Enzalutamide Capsules, 40 mg

Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad


Avient expands healthcare TPU manufacturing in China
News | September 27, 2024

Avient expands healthcare TPU manufacturing in China

Showcases specialty and sustainable materials for healthcare at Medtec China 2024


Takara Bio Europe unveils new large-scale NGS profiling system and chemistries
News | September 27, 2024

Takara Bio Europe unveils new large-scale NGS profiling system and chemistries

The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run


Krsnaa Diagnostics acquires stake in Apulki Healthcare
News | September 27, 2024

Krsnaa Diagnostics acquires stake in Apulki Healthcare

Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita


Rockwell study highlights need for highly skilled workforce for life sciences
News | September 27, 2024

Rockwell study highlights need for highly skilled workforce for life sciences

Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers


Alembic receives USFDA final approval for Paliperidone ER tablets
News | September 27, 2024

Alembic receives USFDA final approval for Paliperidone ER tablets

Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia


Sanofi’s dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Drug Approval | September 27, 2024

Sanofi’s dupixent approved in the US as the first-ever biologic medicine for patients with COPD

Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype


Biocon Biologics Global to raise funds through senior secured notes
News | September 26, 2024

Biocon Biologics Global to raise funds through senior secured notes

The Notes shall not be offered or sold in India